New Awards & Grants Funding Cycle Begins

Adding to Scope of Lung Health Research Contributions

A centerpiece of American Lung Association’s research funding is our Awards & Grants program, which supports the best and brightest scientists who are helping to create a world free from lung disease. 

Indeed, the Lung Association continues to innovate research and we are now looking for new applications. A new funding cycle means new opportunities for scientific progress! To learn more about our research program, visit:  

A few highlights of the work we are currently funding are listed below.

Spotlight on Awardees

With 48 projects receiving funding as part of this latest cycle, we are currently funding 94 awards. Here are a few highlights of the newly funded:


Aparna Balasubramanian, M.D., M.H.S.
Johns Hopkins University-School of Medicine
Investigating Measurement of Pulmonary Vascular Disease in Chronic Obstructive Pulmonary Disease
Catalyst Award

By examining noninvasive approaches for accurately diagnosing pulmonary vascular disease (PVD), this project will help validate two techniques for broader use and then apply the results to recommend treating PVD at an earlier stage.


Francisco Cartujano, M.D.
University of Rochester Medical Center, Wilmot Cancer Institute
Kick Vaping: A Vaping Cessation Text Messaging Intervention for Latino Young Adults
Catalyst Award

Developing and assessing the feasibility, acceptability, and preliminary abstinence rate of Kick Vaping, a text messaging intervention to help Latino young adults stop vaping.


Andrea Pappalardo, M.D.
University of Illinois College of Medicine at Chicago
Stock Albuterol: Preventing Asthma Emergencies in Schools
Public Policy Research Award

This project will analyze the procedures in place for states with stock albuterol laws to apply lessons learned and determine how best to implement stock albuterol policy via an Illinois-based pilot study.


Lara Traeger, Ph.D.
Massachusetts General Hospital
Enhancing Quality of Life in Adults Completing Lung Cancer Treatment with Curative Intent
Innovation Award

We will test a theory-driven quality-of-life program that serves as a bridge from the end of lung cancer treatment to surveillance in order to enhance coping skills for navigating challenges of lung cancer survivorship.


Michael Wells, M.D., MSPH
University of Alabama at Birmingham
Markers of Lung Degradation and Emphysema: A Pilot Study
ACRC Pilot Grant Award

An extension of our Airways Clinical Research CentersLosartan Effects on Emphysema Progression (LEEP) clinical trial, this project aims to understand the biological underpinnings of elastin and collagen degradation in emphysema progression.


Lixing Yang, Ph.D.
The University of Chicago
Discovery of New Oncogenes in Lung Cancers in Never Smokers
Lung Cancer Discovery Award

We will perform detailed studies to discover new disease-causing genes from 2,500 lung cancer tumors in never smokers from across the world. We hope to discover novel drug targets and improve patient care.

Check back in October for our full list of 2021-2022 awardees and funding!

Page last updated: August 5, 2021

No upcoming events near you